| The impact of neurotransmitters on the neurobiology of neurodegenerative diseases SE Davis, AB Cirincione, AC Jimenez-Torres, J Zhu International Journal of Molecular Sciences 24 (20), 15340, 2023 | 6 | 2023 |
| Novel allosteric modulator southern research institute-32743 reverses HIV-1 transactivator of transcription-induced increase in dopamine release in the caudate putamen of … SE Davis, MJ Ferris, S Ananthan, CE Augelli-Szafran, J Zhu Journal of Pharmacology and Experimental Therapeutics 384 (2), 306-314, 2023 | 4 | 2023 |
| Mutations of tyrosine 467 in the human norepinephrine transporter attenuate HIV-1 Tat-induced inhibition of dopamine transport while retaining physiological function MJ Strauss, KD Porter, PM Quizon, SE Davis, S Lin, Y Yuan, ... Plos one 17 (9), e0275182, 2022 | 4 | 2022 |
| Substance abuse and neurotransmission S Davis, J Zhu Advances in Pharmacology 93, 403-441, 2022 | 4 | 2022 |
| Enhancement of fast scan cyclic voltammetry detection of dopamine with tryptophan-modified electrodes SE Davis, AL Korich, ES Ramsson PLoS One 15 (7), e0235407, 2020 | 4 | 2020 |
| Binding mode of human norepinephrine transporter interacting with HIV-1 tat C Adeniran, Y Yuan, SE Davis, C Lin, J Xu, J Zhu, CG Zhan ACS chemical neuroscience 12 (9), 1519-1527, 2021 | 3 | 2021 |
| Molecular mechanisms of dopaminergic transmission in NeuroHIV J Zhu, SE Davis, CG Zhan, JP McLaughlin HIV-Associated Neurocognitive Disorders, 379-398, 2024 | | 2024 |
